CARLSBAD, Calif., Might 02, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Company (NASDAQ: SPNE), a world medical expertise firm centered on surgical options for the therapy of spinal problems, at present introduced the total business launch of OsteoTorrent and OsteoTorrent C, each of that are new Accell DBM Putties packaged and sterilized in a dry state and designed to additional enhance osteoinductive potential and shelf-life, whereas permitting surgeons to reconstitute with saline, blood or bone marrow aspirate. The OsteoTorrent product households construct on SeaSpine’s Evo3®/OsteoSurge® 300 DBMs. The Firm now gives each its best-of-class conventional DBM putties and DBM fibers packaged in a dry state.
“I’m proud to announce the launch of a brand new household of DBM Putty merchandise,” acknowledged Dr. Frank Vizesi, SeaSpine’s Chief Scientific Officer. “OsteoTorrent and OsteoTorrent C had been internally developed, leveraging information gained throughout improvement of OsteoStrand® Plus of the significance of driving moisture out of a DBM to extend its bone forming potential. We acknowledged a chance to enhance our DBM putty merchandise and had been in a position to quickly implement a brand new course of by means of our in-house manufacturing facility in Irvine, California.”
Dr. Gerard Girasole, a Board-Licensed Orthopaedic Surgeon who serves because the chief of Backbone Orthopaedics and medical co-director of the brand new Connecticut Orthopaedic Institute at St. Vincent’s Medical Heart Hartford Health, carried out the primary surgical procedures with OsteoTorrent earlier this month. “OsteoTorrent offers the identical excellent dealing with as Evo3: it packs into any gaps and ensures the graft doesn’t migrate, with the extra advantages of a dry DBM.”
“This launch is a serious milestone that enables SeaSpine to improve our largest product household as an organization, and additional strengthens our place because the #2 DBM provider within the U.S.,” stated Tyler Lipschultz, Senior Vice President, Orthobiologics. “Importantly, it additional demonstrates our R&D group’s scientific self-discipline to isolate, take a look at, and optimize particular person components to ship higher, more cost effective DBMs that compete favorably with lots of the costlier bone grafting options. In the end, we’re executing on our technique to ship scalable and sustainable progress by means of medical worth.”
SeaSpine (www.seaspine.com) is a world medical expertise firm centered on the design, improvement, and commercialization of surgical options for the therapy of sufferers affected by spinal problems. SeaSpine’s full procedural options function its market-leading FLASH™ Navigation, a system designed to enhance accuracy of screw placement and supply a cheap, fast, radiation-free answer to surgical navigation, and a complete portfolio of spinal implants and orthobiologics to fulfill the various combos of merchandise that neurosurgeons and orthopedic backbone surgeons have to facilitate spinal fusion in degenerative, minimally invasive surgical procedure (MIS), and complicated spinal deformity procedures on the lumbar, thoracic and cervical backbone. With product improvement experience in superior optics, software program, orthobiologic sciences and spinal implants, SeaSpine can supply its surgeon clients an entire answer to fulfill their sufferers’ evolving medical wants. SeaSpine presently markets its merchandise in the USA and in roughly 30 international locations worldwide.
SeaSpine cautions you that statements included on this information launch that aren’t an outline of historic info are forward-looking statements which are primarily based on the Firm’s present expectations and assumptions. Such forward-looking statements embrace, however should not restricted to, statements regarding: whether or not the introduced launches show the Firm’s R&D group’s scientific self-discipline and/or execute on its technique to ship scalable and sustainable progress by means of medical worth. Among the many components that might trigger or contribute to materials variations between the Firm’s precise outcomes and the expectations indicated by the forward-looking statements are dangers and uncertainties that embrace, however should not restricted to: the power of newly launched merchandise, comparable to OsteoTorrent and OsteoTorrent C, to carry out as designed and supposed and to fulfill the wants of surgeons and sufferers, together with because of the dearth of considerable medical validation of merchandise following restricted business (or “alpha”) launch; and different dangers and uncertainties extra totally described within the Firm’s information releases and periodic filings with the Securities and Trade Fee. The Firm’s public filings with the Securities and Trade Fee can be found at www.sec.gov.
You’re cautioned to not place undue reliance on forward-looking statements, which communicate solely as of the date when made. SeaSpine doesn’t intend to revise or replace any forward-looking assertion set forth on this information launch to replicate occasions or circumstances arising after the date hereof, besides as could also be required by regulation.
Investor Relations Contact